Guo-hui Cui
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study.
Journal: EBioMedicine
Published: December 09, 2024
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.
Journal: Cancer communications (London, England)
Published: August 13, 2024
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: February 24, 2024
Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.
Journal: EClinicalMedicine
Published: July 13, 2022
Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.
Journal: Acta pharmacologica Sinica
Published: December 14, 2013
Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy in patients with chronic myeloid leukemia: two cases report and literatures review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 23, 2013
Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro.
Journal: Acta pharmacologica Sinica
Published: October 16, 2012
Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate.
Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate.
Journal: Chinese medical journal
Published: August 14, 2012
Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS.
Journal: Oncology letters
Published: December 27, 2011
Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1.
Journal: Acta pharmacologica Sinica
Published: December 14, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026